Delivery Order SPE2DB22D1017-SPE2DB25FG3UN
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,550.49 firm-fixed-price delivery order is for the supply of 100 capsules of the drug Tacrolimus 1 mg, which is used for immunosuppression. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,201.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,996,433 units of the medication Tacrolimus 5 mg Capsule (IR) 100s, with a completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.89, is for the delivery of 100 capsules of the medication Tacrolimus 5 mg. The contract has a performance period that extends through May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of 5 mg Tacrolimus capsules. The $1,903.26 contract has a period of performance through March 22, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is the sole awardee of a $999,999,999.00 indefinite delivery contract from DLA to deliver pharmaceuticals...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,474.11 firm fixed-price delivery order is for the supply of 100 capsules of 5 mg Tacrolimus (an immunosuppressant medication). The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2022. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tacrolimus 1 mg capsules. The contract is a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2025, which provides a broad range of medical commodities to support military treatment programs and facilities worldwide. The Delivery Order has a ceiling value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,412.10 firm fixed-price delivery order is for Tacrolimus 1 mg capsules, with an ultimate completion date of October 28, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,925.04, is for the delivery of TACROLIMUS 0.5 MG CAPSULE (IR) 100S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 15, 2024 and is structured as a Firm Fixed Price Delivery Order. This...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFGYT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,514.52 firm fixed-price delivery order is for the supply of 100 capsules of the drug Tacrolimus 1 mg, an immunosuppressant medication. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules. The contract has a ceiling value of $3,298.32 and runs through January 8, 2025. It is a firm fixed-price contract, with no set-aside requirement indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...